# A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort

> **NCT06492174** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Boston Scientific Corporation** · enrollment: 20 (actual)

## Conditions studied

- In-Stent Restenosis

## Interventions

- **DEVICE:** AGENT DCB 40 mm

## Key facts

- **NCT ID:** NCT06492174
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-07
- **Primary completion:** 2025-12-19
- **Final completion:** 2027-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06492174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06492174, "A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06492174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*